MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$16.20 -0.48 (-2.88%)
Open Price: 16.68
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients